Stockreport

UPDATE 3-Regenxbio to receive $370 mln upfront in gene therapy deal with AbbVie [Reuters]

REGENXBIO Inc.  (RGNX) 
Last regenxbio inc. earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.regenxbio.com
PDF and sell an experimental gene therapy for the treatment of chronic retinal diseases, the companies said on Monday. Shares of the Regenxbio, which could potentially rec [Read more]